NASDAQ: NDSN
Nordson
Industrials · General Industrial Machinery & Equipment, NEC
52-week range
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.$16.6B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 31, 2016 | $5.74B |
| FY2017, ended Oct 31, 2017 | $7.32B |
| FY2018, ended Oct 31, 2018 | $7.11B |
| FY2019, ended Oct 31, 2019 | $9.05B |
| FY2020, ended Oct 31, 2020 | $11.2B |
| FY2021, ended Oct 31, 2021 | $14.8B |
| FY2022, ended Oct 31, 2022 | $12.9B |
| FY2023, ended Oct 31, 2023 | $12.1B |
| FY2024, ended Oct 31, 2024 | $14.1B |
| FY2025, ended Oct 31, 2025 | $12.9B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $16.6B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.$2.98B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 31, 2016 | $1.81B |
| FY2017, ended Oct 31, 2017 | $2.07B |
| FY2018, ended Oct 31, 2018 | $2.25B |
| FY2019, ended Oct 31, 2019 | $2.19B |
| FY2020, ended Oct 31, 2020 | $2.12B |
| FY2021, ended Oct 31, 2021 | $2.36B |
| FY2022, ended Oct 31, 2022 | $2.59B |
| FY2023, ended Oct 31, 2023 | $2.63B |
| FY2024, ended Oct 31, 2024 | $2.69B |
| FY2025, ended Oct 31, 2025 | $2.79B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $2.98B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 31, 2016 | $272M | $274M |
| FY2017, ended Oct 31, 2017 | $296M | $285M |
| FY2018, ended Oct 31, 2018 | $377M | $415M |
| FY2019, ended Oct 31, 2019 | $337M | $319M |
| FY2020, ended Oct 31, 2020 | $250M | $452M |
| FY2021, ended Oct 31, 2021 | $454M | $508M |
| FY2022, ended Oct 31, 2022 | $513M | $462M |
| FY2023, ended Oct 31, 2023 | $487M | $607M |
| FY2024, ended Oct 31, 2024 | $467M | $492M |
| FY2025, ended Oct 31, 2025 | $484M | $661M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $555M | $724M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.$113M
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 31, 2016 | $67.2M |
| FY2017, ended Oct 31, 2017 | $90.4M |
| FY2018, ended Oct 31, 2018 | $95.7M |
| FY2019, ended Oct 31, 2019 | $151M |
| FY2020, ended Oct 31, 2020 | $208M |
| FY2021, ended Oct 31, 2021 | $300M |
| FY2022, ended Oct 31, 2022 | $163M |
| FY2023, ended Oct 31, 2023 | $116M |
| FY2024, ended Oct 31, 2024 | $116M |
| FY2025, ended Oct 31, 2025 | $108M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $113M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.$1.92B
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 31, 2016 | $981M |
| FY2017, ended Oct 31, 2017 | $1.58B |
| FY2018, ended Oct 31, 2018 | $1.31B |
| FY2019, ended Oct 31, 2019 | $1.24B |
| FY2020, ended Oct 31, 2020 | $1.11B |
| FY2021, ended Oct 31, 2021 | $812M |
| FY2022, ended Oct 31, 2022 | $738M |
| FY2023, ended Oct 31, 2023 | $1.73B |
| FY2024, ended Oct 31, 2024 | $2.19B |
| FY2025, ended Oct 31, 2025 | $2.00B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $1.92B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.9% since 2016.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.55.7M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 31, 2016 | 57.3M |
| FY2017, ended Oct 31, 2017 | 57.7M |
| FY2018, ended Oct 31, 2018 | 57.9M |
| FY2019, ended Oct 31, 2019 | 57.7M |
| FY2020, ended Oct 31, 2020 | 58.1M |
| FY2021, ended Oct 31, 2021 | 58.2M |
| FY2022, ended Oct 31, 2022 | 57.2M |
| FY2023, ended Oct 31, 2023 | 57.0M |
| FY2024, ended Oct 31, 2024 | 57.0M |
| FY2025, ended Oct 31, 2025 | 55.8M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | 55.7M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Jul 31, 2026. Hover or tap a column for another year.Net: $171M more bought back than issued
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Oct 31, 2016 | $33.4M | $18.2M | $11.5M |
| FY2017, ended Oct 31, 2017 | $3.22M | $20.2M | $14.1M |
| FY2018, ended Oct 31, 2018 | $24.0M | $21.6M | $18.8M |
| FY2019, ended Oct 31, 2019 | $121M | $18.1M | $26.0M |
| FY2020, ended Oct 31, 2020 | $52.6M | $12.9M | $50.9M |
| FY2021, ended Oct 31, 2021 | $61.0M | $22.8M | $31.8M |
| FY2022, ended Oct 31, 2022 | $263M | $30.7M | $12.1M |
| FY2023, ended Oct 31, 2023 | $89.7M | $22.7M | $21.4M |
| FY2024, ended Oct 31, 2024 | $33.3M | $19.0M | $31.1M |
| FY2025, ended Oct 31, 2025 | $306M | $18.9M | $9.01M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $247M | $23.2M | $52.7M |
Revenue (TTM)
$2.98B
+7.0% YoY
Net income (TTM)
$555M
+22.0% YoY
Cash
$113M
−23.2% YoY
Total debt
$1.92B
−3.7% YoY
Valuation
At current price- Market Cap
- $18.0B
- P/E
- 32.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.0×
- Price / Book
- 5.5×
- EV / EBITDA
- 22.6×
Growth
Trailing 12 months- Revenue (TTM)
- $2.98B
- Revenue Growth YoY
- 7.0%
- Revenue CAGR 3Y
- 2.5%
- Revenue CAGR 5Y
- 5.6%
- EPS Growth YoY
- 24.3%
- Net Income Growth YoY
- 22.0%
Profitability
Trailing 12 months- Gross Margin
- 55.3%
- Operating Margin
- 26.9%
- Net Margin
- 18.6%
- FCF Margin
- 24.3%
- Return on Equity
- 17.8%
Earnings
Trailing 12 months- Net Income
- $555M
- EPS (diluted)
- $9.88
- EBITDA
- $877M
- Operating Income
- $801M
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $113M
- Total Debt
- $1.92B
- Net Debt
- $1.81B
- Total Assets
- $5.95B
- Total Liabilities
- $2.68B
- Shareholders' Equity
- $3.27B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $773M
- Capital Expenditure
- $49.4M
- Free Cash Flow
- $724M
Dividends and risk
Last 12 months- Dividend Yield
- 1.1%
- Dividend / Share
- $3.40
- Beta (5Y)
- 0.98
Every ratio is calculated from the company’s reported figures.
Strength
Revenue is up 7.0% year over year, at $2.98B.
Strength
Operating margin widened 2.6 pts in a year, to 26.9%.
Note
Net debt of $1.81B is 2.1× EBITDA.
Strength
Turns 24.3% of revenue into free cash flow.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-K for the fiscal year ended Oct 31, 2025 · filed Dec 17, 2025
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2024 · 10-K59Nothing notable
10-K for the fiscal year ended Oct 31, 2024
Filed Dec 18, 2024 · Read the filing on EDGAR
- Sales rose 2.3% to $2.69 billion, but only because of acquisitions; organic sales fell 2.5%, led by an 11.4% drop in the Advanced Technology segment.
- Operating profit was nearly flat at $674 million, while net income fell 4.1% to $467 million, mainly because interest expense rose 49.4%.
- Nordson bought medical device maker Atrion for about $790 million using borrowings and cash, lifting total debt to about $2.22 billion.
- Operating cash flow fell to $556 million from $641 million, though management still calls its liquidity more than adequate.
Business momentum
Stable
“Sales $ 2,689,921 2.3 % $ 2,628,632 1.5 % $ 2,590,278”
Outlook
Neutral
“is expected to be more than adequate to fund our liquidity needs over the twelve months and the foreseeable future thereafter”
Financial stress
Low
“Our operating performance, balance sheet position and financial ratios for 2024 remained strong.”
Tone against the previous report
About the same
Red flags
None found in this report.
Positives
Gross margin improved by one percentage point to 55.2%
“Gross margins improved 1.0 percentage point reflecting the impact of favorable product mix”
Strong cash generation and large unused borrowing capacity
“available borrowings under our loan agreements and unused bank lines of credit which totaled $785,880 as of October 31, 2024”
No goodwill write-downs despite heavy acquisition spending
“We did not record any goodwill impairment charges in 2024.”
Concerns
Weak underlying demand, especially in electronics and test equipment
“The ATS organic sales decrease of 11.4 percent was driven by lower demand in electronics dispense product lines as well as test and inspection product lines.”
Higher interest costs from acquisition debt reduced earnings
“The decrease of $0.35 per diluted share was primarily driven by higher interest expense in 2024 compared to 2023.”
Operating cash flow fell as customer advances and taxes payable declined
“The changes in operating assets and liabilities were principally driven by decreases in customer advance payments and income taxes payable.”
New risks since the previous report
Proposed large US tariffs under the incoming administration
“the incoming U.S. presidential administration has proposed to significantly increase tariffs on foreign imports into the United States, particularly from Canada, China and Mexico”
Atrion purchase may not deliver expected benefits
“we cannot assure that any acquisition, including the recent acquisitions of Atrion, the ARAG Group ("ARAG") and CyberOptics Corporation ("CyberOptics"), once successfully integrated, will perform as planned”
Biggest risks named
- Economic slowdowns in cyclical customer markets such as electronics
- Acquisitions such as Atrion and ARAG underdelivering, including possible goodwill write-downs
- Higher debt, loan covenants and interest rates
- US tariffs and trade policy changes under the incoming administration
- Currency swings, with about two-thirds of revenue outside the U.S.
Artificial intelligence in this business: Not mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | 0 | |
| Outlook | 0 | |
| Tone against the previous report | 0 | |
| Financial stress | 0 | |
| Red flags | 0 | |
| New risks | −1 | |
| Score | 59 | |
Written by AI (Claude Opus 5.5) from the report’s text. 11 of 11 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-K | Dec 17, 2025 | Pro | |||
| 10-K | Dec 18, 2024 | 59 | Stable | None | |
| 10-K | Dec 20, 2023 | 56 | Mixed | None | |
| 10-K | Dec 19, 2022 | 64 | Improving | None | |
| 10-K | Dec 17, 2021 | 75 | Strong improvement | None | |
| 10-K | Dec 18, 2020 | 54 | Weakening | 1 medium | |
| 10-K | Dec 13, 2019 | 49 | Weakening | None | |
| 10-K | Dec 14, 2018 | 70 | Strong improvement | None | |
| 10-K | Dec 15, 2017 | 70 | Improving | None | |
| 10-K | Dec 15, 2016 | 71 | Strong improvement | None |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q3 FY2026 (period ended Jul 31, 2026), filed Aug 20, 2026. View filings on SEC EDGAR